Tag:
PNT2258
Latest Headlines
Latest Headlines
ProNAi tests 'Smarticles' delivery tech in trials
Kalamazoo-MI-based ProNAi Therapeutics has launched Phase I clinical trials in Texas for its anti-tumor drug candidate, PNT2258, using a drug delivery technology licensed by Marina Biotech. "We are
